首頁 > 市場調查報告書 > 醫療設備

整形外科

關節內粘稠補充療法市場規模、佔有率和成長分析（按產品、應用、原料、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1914053

關節內粘稠補充療法市場規模、佔有率和成長分析（按產品、應用、原料、最終用戶和地區分類）－2026-2033年產業預測

Viscosupplementation Market Size, Share, and Growth Analysis, By Product (Introduction, Single Injection), By Application (Introduction, Knee Osteoarthritis), By Source, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年01月02日 | 出版商:

SkyQuest | 英文 183 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球關節內粘稠補充療法市場規模將達到 53.8 億美元，到 2025 年將達到 56.8 億美元，到 2033 年將達到 87.1 億美元，預測期（2026-2033 年）的複合年成長率為 5.5%。

全球關節內粘稠補充療法市場正穩定成長，主要驅動力是骨關節炎發病率的上升，尤其是在老年人中。隨著對非侵入性治療方法需求的不斷成長，黏液補充療法已成為理想的治療方法，有望延緩關節手術。透明質酸產品的進步以及人們對微創手術日益成長的偏好進一步提升了市場的吸引力。關鍵關節內粘稠補充療法成長要素包括人們對維持身體機能的日益重視以及運動相關傷害的急劇增加。然而，高昂的治療費用、保險覆蓋範圍的限制以及不同患者群體療效的差異等挑戰也阻礙了市場擴張。此外，皮質類固醇注射、物理治療和口服藥物等替代療法的出現，以及不斷變化的法規環境和地區報銷政策的差異，都進一步加劇了市場動態的複雜性。

推動全球關節內粘稠補充療法市場發展的因素

骨關節炎發生率的上升，尤其是在老年人中，是全球關節內粘稠補充療法市場成長的主要驅動力。隨著老齡化，關節劣化的風險增加，從而推動了對非手術鎮痛方法（例如透明質酸注射）的需求。這種傾向於微創療法而非全關節置換術等侵入性手術的趨勢，正在已開發市場和新興市場推動黏性補充療法的擴張。因此，對有效替代療法的需求不僅滿足了老齡化社會的需求，也刺激了關節內粘稠補充療法領域的創新和投資。

全球關節內粘稠補充療法市場面臨的限制因素

全球關節內粘稠補充療法市場面臨許多限制因素，其中之一是用於該療法的先進或品牌透明質酸製劑高成本。此外，不同地區保險覆蓋範圍的差異或限制也可能阻礙患者選擇此療法。醫療系統面臨的經濟負擔，加上病患的自付費用，嚴重阻礙了關節內粘稠補充療法術的普及，尤其是在價格敏感度較高的市場。這可能會抑制該療法的整體發展和應用，限制有需要的患者獲得治療的機會。

全球關節內粘稠補充療法市場趨勢

全球關節內粘稠補充療法市場正經歷著向單次注射和長效製劑的顯著轉變，這主要得益於患者和醫療服務提供者對便捷治療方案日益成長的偏好。單次注射玻尿酸療法簡化了治療流程，縮短了診所就診時間，降低了手術風險，從而提高了患者滿意度。同時，長效製劑的推出能夠持續潤滑關節並緩解疼痛，從而提高患者依從性並改善臨床療效。這一趨勢與門診護理的整體變革相吻合，門診護理強調以經濟有效的方式管理骨關節炎，並致力於創造一個鼓勵創新治療方案的環境。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Sanofi SA（France）
Anika Therapeutics, Inc.（United States）
SEIKAGAKU CORPORATION（Japan）
Zimmer Biomet Holdings, Inc.（United States）
Bioventus Inc.（United States）
Fidia Farmaceutici SpA（Italy）
Ferring Pharmaceuticals（Switzerland）
Johnson & Johnson（United States）
Smith & Nephew plc（United Kingdom）
Avanos Medical, Inc.（United States）
LG Chem, Ltd.（South Korea）
IBSA Institut Biochimique SA（Switzerland）
Hoffmann-La Roche Ltd.（Switzerland）
Teva Pharmaceutical Industries Ltd.（Israel）
Viatris Inc.（United States）
Lifecore Biomedical, LLC（United States）
Aptissen SA（Switzerland）
Chugai Pharmaceutical Co., Ltd.（Japan）
Kolon TissueGene, Inc.（South Korea）
TRB CHEMEDICA SA（Switzerland）

結論與建議

簡介目錄

Product Code: SQMIG35B2276

Global Viscosupplementation Market size was valued at USD 5.38 Billion in 2024 and is poised to grow from USD 5.68 Billion in 2025 to USD 8.71 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The global viscosupplementation market is witnessing consistent growth, primarily driven by the rising incidence of osteoarthritis, especially among the aging population. As demand for non-invasive treatment options escalates, viscosupplementation emerges as a preferred therapy capable of postponing joint surgeries. Advances in hyaluronic acid-based products and a growing preference for minimally invasive procedures further enhance market appeal. Key growth factors include an increased focus on physical mobility and the surging prevalence of sports-related injuries. Nonetheless, market expansion faces challenges such as high treatment costs, reimbursement hurdles, and varying efficacy among patient demographics. Additional alternatives like corticosteroid injections, physical therapy, and oral medications, along with regulatory shifts and regional reimbursement policies, also complicate market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Viscosupplementation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Viscosupplementation Market Segments Analysis

Global Viscosupplementation Market is segmented by Product, Application, Source, End User and region. Based on Product, the market is segmented into Introduction, Single Injection, Three Injection and Five Injection. Based on Application, the market is segmented into Introduction, Knee Osteoarthritis, Hip Osteoarthritis, Shoulder Osteoarthritis and Other Applications. Based on Source, the market is segmented into Introduction, Animal Source and Non-Animal Source. Based on End User, the market is segmented into Introduction, Hospitals, Orthopedic Clinics/Ambulatory Surgical Centers (ASCS), Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Viscosupplementation Market

The rising incidence of osteoarthritis, particularly among older adults, significantly propels the growth of the global viscosupplementation market. As individuals age, they face heightened risks of joint deterioration, leading to a greater demand for non-surgical pain relief options, such as hyaluronic acid injections. This trend towards minimally invasive therapies, preferred over more invasive procedures like total joint replacements, fosters expansion in both advanced and emerging markets. Consequently, the push for effective alternatives to manage joint pain not only addresses the needs of the aging population but also encourages innovation and investment within the viscosupplementation sector.

Restraints in the Global Viscosupplementation Market

The global viscosupplementation market faces significant restraints due to the high costs associated with advanced or branded hyaluronic acid formulations used in these procedures. Additionally, inconsistent or limited reimbursement policies in various regions can deter patients from pursuing this treatment option. This financial burden on healthcare systems, coupled with out-of-pocket expenses for patients, poses a substantial barrier to broader acceptance of viscosupplementation, particularly in markets where price sensitivity is a critical concern. As a result, the overall growth and adoption of these procedures can be hindered, limiting their availability and accessibility to those in need.

Market Trends of the Global Viscosupplementation Market

The Global Viscosupplementation market is witnessing a significant shift towards single-injection and long-acting formulations, driven by a growing preference for convenient treatment options among patients and healthcare providers. Single-injection hyaluronic acid therapies streamline the treatment process, reducing clinic time and procedural risks, thus enhancing patient satisfaction. Simultaneously, the introduction of long-acting formulations offers extended joint lubrication and sustained pain relief, leading to improved patient compliance and clinical outcomes. This trend aligns with broader changes in outpatient care, highlighting a cost-effective approach to osteoarthritis management while fostering an environment conducive to innovative treatment solutions.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Viscosupplementation Market Size by Product & CAGR (2026-2033)

Market Overview
Introduction
Single Injection
Three Injection
Five Injection

Global Viscosupplementation Market Size by Application & CAGR (2026-2033)

Market Overview
Introduction
Knee Osteoarthritis
Hip Osteoarthritis
Shoulder Osteoarthritis
Other Applications

Global Viscosupplementation Market Size by Source & CAGR (2026-2033)

Market Overview
Introduction
Animal Source
Non-Animal Source

Global Viscosupplementation Market Size by End User & CAGR (2026-2033)

Market Overview
Introduction
Hospitals
Orthopedic Clinics/Ambulatory Surgical Centers (ASCS)
Retail Pharmacies
Online Pharmacies

Global Viscosupplementation Market Size & CAGR (2026-2033)

North America (Product, Application, Source, End User)
- US
- Canada
Europe (Product, Application, Source, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, Source, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, Source, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, Source, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anika Therapeutics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SEIKAGAKU CORPORATION (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fidia Farmaceutici S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avanos Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LG Chem, Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBSA Institut Biochimique SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viatris Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifecore Biomedical, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptissen SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chugai Pharmaceutical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kolon TissueGene, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TRB CHEMEDICA SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments